Funding CCSVI research is/was a waste of valuable time, money and intellectual energy: Yes

Multiple Sclerosis Journal

Volumn 19, Issue 7, 2013, Pages 855-857

  Ghezzi, Angelo ^a  

^a Ospedale di Gallarate   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ARTICLE; BRAIN MICROCIRCULATION; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; COLOR ULTRASOUND FLOWMETRY; EPSTEIN BARR VIRUS; ERYTHROCYTE; FUNDING; GOLD STANDARD; HEMODYNAMICS; HISTORY OF MEDICINE; HUMAN; IMMUNOTHERAPY; INTERNET; MULTIPLE SCLEROSIS; NEUROIMAGING; PREDICTIVE VALUE; PREVALENCE; REPRODUCIBILITY; SOCIAL MEDIA; VEIN BLOOD FLOW; VENOUS RETURN;

EID: 84878364560     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513479825     Document Type: Article

References (15)

1. Zamboni P. The big idea: Iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006 ; 99: 589-593
2. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009 ; 80: 392-399
3. Zamboni P, Bertolotto A, Boldrini P, et al. Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams study (Brain Venous Drainage Exploited Against Multiple Sclerosis): Study protocol for a randomized controlled trial. Trials. 2012 ; 13: 183
4. Baracchini C, Atzori M, Gallo P. CCSVI and MS: No meaning, no fact. Neurol Sci. 2012 ;:
5. Bagert BA, Marder E, Stüve O. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Arch Neurol. 2011 ; 68: 1379-1384
6. Amato M, Saia V, Hakiki B, et al. No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. Mult Scler. 2012 ; 18: 1791-1796
7. Filippi M, Rocca MA, Barkhof F, et al. Multiple sclerosis and chronic cerebrospinal venous insufficiency: The neuroimaging perspective. AJNR Am J Neuroradiol. 2011 ; 3: 1-3
8. D'haeseleer M, Cambron M, Vanopdenbosch L, et al. Vascular aspects of multiple sclerosis. Lancet Neurol. 2011 ; 10: 657-666
9. Comi G, Battaglia MA, Bertolotto A, et al. Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): Rationale, design, and methodology. Neurol Sci. 2013 ;:
10. Zamboni P, Galeotti R, Weinstock-Guttman B, et al. Venous angioplasty in patients with multiple sclerosis: Results of a pilot study. Eur J Vasc Endovasc Surg. 2012 ; 43: 116-122
11. Ghezzi A, Annovazzi P, Cocco E, et al. Endovascular treatment of CCSVI in patients with multiple sclerosis: Clinical outcome of 462 cases. Neurol Sci. 2013 ;:
12. Ghezzi A, Annovazzi P, Amato MP, et al. Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. Mult Scler. 2013 ;:
13. United States Food and Drug Administration. FDA Safety Communication: Chronic cerebrospinal venous insufficiency treatment in multiple sclerosis patients, http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm303318. htm#.T6vm8Mc8cjc.email (10May2012, accessed 31 Jan 2013).
14. Reekers JA, Lee MJ, Belli AM, et al. Cardiovascular and Interventional Radiological Society of Europe Commentary on the treatment of chronic cerebrovascular venous insufficiency. Cardiovasc Intervent Radiol. 2011 ; 34: 1-2
15. Baracchini C, Valdueza JM, Del Sette M, et al. CCSVI and MS: A statement from the European Society of Neurosonology and Cerebral Hemodynamics. J Neurol. 2012 ; 259: 2585-2589